Cynosure Inc.

Electronic Components & Devices

Cynosure Receives Regulatory Clearance in China to Market PicoSure® Picosecond Laser for Tattoo Removal

WESTFORD, Mass., - Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the PicoSure 755 nm wavelength for tattoo removal. The product will be marketed through the Company's direct sales force in...

Read More »
Electronic Components & Devices

Cynosure Announces FDA Clearance of New 532 nm Laser Delivery System for PicoSure®

New System Slated for Introduction at American Academy of Dermatology 2015 Annual Meeting WESTFORD, Mass., -- Cynosure, Inc. (NASDAQ: CYNO) today announced FDA 510(k) clearance of its new 532 nm Laser Delivery System for PicoSure®, creating a powerful, dual-wavelength laser system for removing tattoos of all colors in fewer treatments. PicoSure, the world's first picosecond aesthetic...

Read More »
Electronic Components & Devices

Anti-Aging System uses 1,320 nm Nd:YAG laser.

Incorporating 3 energy sources, Affirm(TM) Workstation uses 1,320 nm Nn:YAG laser for tissue tightening through deep-heating, 1,440 nm Nd:YAG laser for fractional micro-rejuvenation, and Xenon Pulsed Light system for discoloration. Combined Apex Pulse(TM) technology redistributes laser energy in combination of high and low level heat to stimulate and remodel collagen production, while Multiplex...

Read More »
Electronic Components & Devices

Laser Workstation suits aesthetic and medical practices.

Cynergy III Aesthetic Workstation includes 2 lasers plus breakaway pulsed light system that can be used in workstation or can be unplugged for use at other locations. Baby-safe pulse dye laser technology is suited for treating vascular lesions and fine telangiectasias, while skin-safe Nd:YAG laser removes hair and treats larger veins on face and legs. Wavelengths from 500-950 nm treat red and...

Read More »
Electronic Components & Devices

Cynosure Receives Regulatory Clearance in China to Market PicoSure® Picosecond Laser for Tattoo Removal

WESTFORD, Mass., - Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the PicoSure 755 nm wavelength for tattoo removal. The product will be marketed through the Company's direct sales force in...

Read More »
Electronic Components & Devices

Cynosure Announces FDA Clearance of New 532 nm Laser Delivery System for PicoSure®

New System Slated for Introduction at American Academy of Dermatology 2015 Annual Meeting WESTFORD, Mass., -- Cynosure, Inc. (NASDAQ: CYNO) today announced FDA 510(k) clearance of its new 532 nm Laser Delivery System for PicoSure®, creating a powerful, dual-wavelength laser system for removing tattoos of all colors in fewer treatments. PicoSure, the world's first picosecond aesthetic...

Read More »
Company News

Cynosure to Present at 10th Annual Needham Healthcare Conference

Presentation to be Webcast Live at 2:00 p.m. ET Tuesday, April 5 WESTFORD, Mass., March 28, 2011 - Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the 10th Annual Needham Healthcare Conference in New York City. The presentation by President and Chief Executive Officer Michael...

Read More »
Company News

Cynosure to Present at 4th Annual Maxim Group Growth Conference

Presentation to be Webcast Live at 1:30 p.m. ET Thursday, November 18 WESTFORD, Mass., Nov. 10, 2010 -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the Maxim Group Growth Conference in New York on Thursday, November 18. The presentation by Executive Vice President,...

Read More »
Company News

Cynosure to Present at UBS Global Life Sciences Conference

Presentation to be Webcast Live at 3:00 p.m. ET Tuesday, September 21 WESTFORD, Mass., Sept. 16 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21. The presentation by President and Chief Executive...

Read More »
Company News

Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences

WESTFORD, Mass., March 11 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Tim Baker will present at the following institutional investor conferences in March: o On Monday, March 17, the Company will present at the...

Read More »
Company News

Cynosure to Webcast Presentation from 10th Annual Needham & Company Growth Conference

WESTFORD, Mass., Jan. 2 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that its senior management will be presenting at the 10th Annual Needham & Company Growth Conference. The conference is being held January 8 - 11 at The New York Palace Hotel. Cynosure's presentation will be webcast live over...

Read More »
Company News

Cynosure to Present at the RBC Capital Markets Healthcare Conference

WESTFORD, Mass., Dec. 5 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the RBC Capital Markets Healthcare Conference on Wednesday, December 12, 2007 at 10:00 a.m. ET from The Westin New York at Times Square, New York. President and Chief Executive Officer Michael...

Read More »
Company News

Cynosure to Present at the Citigroup 2007 Healthcare Conference

WESTFORD, Mass., May 15: Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the upcoming Citigroup Healthcare Conference on Tuesday, May 22, 2007 at 1:20 p.m. ET from the New York Hilton. President and Chief Executive Officer Michael Davin and Chief Financial Officer...

Read More »
Electronic Components & Devices

Anti-Aging System uses 1,320 nm Nd:YAG laser.

Incorporating 3 energy sources, Affirm(TM) Workstation uses 1,320 nm Nn:YAG laser for tissue tightening through deep-heating, 1,440 nm Nd:YAG laser for fractional micro-rejuvenation, and Xenon Pulsed Light system for discoloration. Combined Apex Pulse(TM) technology redistributes laser energy in combination of high and low level heat to stimulate and remodel collagen production, while Multiplex...

Read More »

All Topics